糖尿病合并细菌性肝脓肿患者的临床特点分析
作者:
作者单位:

1.安徽医科大学第一附属医院感染病科;2.安徽省细菌耐药监控中心;3.安徽医科大学细菌耐药研究所

作者简介:

通讯作者:

李家斌  E-mail: lijiabin@ahmu.edu.cn

中图分类号:

R575.4

基金项目:

国家自然科学基金项目(81973983、82270015)


Clinical characteristics of patients with diabetes complicated with pyogenic liver abscess
Author:
Affiliation:

1.Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China;2.Anhui Center for Survei-llance of Bacterial Antimicrobial Resistance, Hefei 230022, China;3.Institute of Bacterial Antimicrobial Resistance, Anhui Medical University, Hefei 230022, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 比较糖尿病(DM)合并肝脓肿(PLA)与非糖尿病(NDM)合并PLA患者之间的临床特征,以期为临床诊断及治疗提供依据。 方法 选取安徽医科大学某附属医院2002年7月—2022年2月收治的PLA患者,按照是否合并DM分为DM+PLA组和NDM+PLA组。回顾性分析两组患者的一般情况、临床表现和体征、并发症、生化和病原学检查结果、影像学表现、临床疗效及影响因素。 结果 共纳入PLA患者695例,其中DM+PLA组191例(27.5%),NDM+PLA组504例(72.5%)。DM+PLA组患者中男性、合并高血压的占比高于NDM+PLA组,而胆道疾病及恶性肿瘤占比低于NDM+PLA组(均P < 0.05)。DM+PLA组患者出现发热,乏力,并发贫血、低蛋白血症的占比高于NDM+PLA组(均P < 0.05)。与NDM+PLA组相比,DM+PLA组患者中性粒细胞计数、中性粒细胞百分比升高,而总蛋白、清蛋白含量及清蛋白/球蛋白比值均降低(均P < 0.05)。DM+PLA组患者肺炎克雷伯菌检出、肝右叶脓肿发生的占比较NDM+PLA组更高(均P < 0.05)。多因素logistic回归分析发现,恶性肿瘤是影响PLA患者临床疗效的危险因素,侵入性治疗是影响PLA患者临床疗效的保护因素,而血糖是影响NDM+PLA组患者临床疗效的危险因素。 结论 DM+PLA较NDM+PLA患者感染症状重,且伴有更高的肺炎克雷伯菌感染和肝右叶脓肿的比例。应加强对恶性肿瘤患者的关注,控制好血糖水平,必要时应及时辅以侵入性治疗手段。

    Abstract:

    Objective To compare the clinical characteristics of diabetes mellitus (DM) patients complicated with pyogenic liver abscess (PLA) and non-DM (NDM) patients complicated with PLA, and provide evidence for clinical diagnosis and treatment. Methods PLA patients who admitted to an affiliated hospital of Anhui Medical University from July 2002 to February 2022 were selected and divided into DM+PLA group and NDM+PLA group according to whether they had DM. General condition, clinical manifestations and signs, complications, biochemical and patho- genic examination results, imaging findings, as well as clinical efficacy and influencing factors of the two groups of patients were analyzed retrospectively. Results 695 PLA patients were included in the analysis, 191 (27.5%) in the DM+PLA group and 504 (72.5%) in the NDM+PLA group. The proportions of males and complication of hypertension in the DM+PLA group were higher than those in the NDM+PLA group, while the proportion of bi-liary diseases and malignant tumors was lower (all P < 0.05). The proportions of patients developing fever, fatigue, as well as concurrent anemia and hypoalbuminemia in the DM+PLA group were higher than those in the NDM+PLA group (all P < 0.05). Compared with the NDM+PLA group, the neutrophil count and percentage in the DM+PLA group increased, while total protein, albumin content, and albumin/globulin ratio all decreased (all P < 0.05). The proportions of the detection of Klebsiella pneumoniae and the occurrence of liver right lobe abscess in DM+PLA patients were higher than those of the NDM+PLA group (both P < 0.05). Multivariate logistic regression analysis revealed that malignant tumor was a risk factor for affecting the clinical efficacy of PLA patients, invasive treatment was a protect factor for affecting the clinical efficacy of PLA patients, while blood sugar was a risk factor for affecting the clinical efficacy of NDM+PLA patients. Conclusion DM+PLA patients have more severe infection symptoms than NDM+PLA patients, and are accompanied by higher proportions of Klebsiella pneumoniae infection and liver right lobe abscess. It is necessary to strengthen attention to patients with malignant tumor and control blood sugar level, and timely supplement with invasive treatment if necessary.

    参考文献
    相似文献
引用本文

李旭峰,郑亚虹,杨懿,等.糖尿病合并细菌性肝脓肿患者的临床特点分析[J]. 中国感染控制杂志,2024,23(6):674-679. DOI:10.12138/j. issn.1671-9638.20244717.
Xu-feng LI, Ya-hong ZHENG, Yi YANG, et al. Clinical characteristics of patients with diabetes complicated with pyogenic liver abscess[J]. Chin J Infect Control, 2024,23(6):674-679. DOI:10.12138/j. issn.1671-9638.20244717.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-12-13
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-18
  • 出版日期: